Rive Sarfstein

1.9k citations
51 papers · 1.5k indexed · h-index 26

Rive Sarfstein

51 papers receiving 1.5k citations

Peers

Rive Sarfstein
Comparison fields: 5 of 94
  • Endocrinology, Diabetes and Metabolism 471
  • Cancer Research 388
  • Molecular Biology 899
  • Immunology 202
  • Oncology 244
Replace Hitomi Imachi with:
Hitomi Imachi Japan
Tsuyoshi Kadomatsu Japan
Jan‐Wilhelm Kornfeld Germany
Hisakazu Iwama Japan
Larbi Amazit France
Péter Igaz Hungary
Silvia Cantara Italy
Inmaculada Ibañez de Cáceres Spain
Henriett Butz Hungary
Lynn Cheatham United States
Rive Sarfstein relative to Hitomi Imachi Japan Hitomi Imachi's profile →
Citations per field
00.5×1.5×
Hitomi Imachi · 1×
Citations per year

Countries citing papers authored by Rive Sarfstein

Since Specialization
Citations

This map shows the geographic impact of Rive Sarfstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rive Sarfstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rive Sarfstein more than expected).

Fields of papers citing papers by Rive Sarfstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rive Sarfstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rive Sarfstein. The network helps show where Rive Sarfstein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rive Sarfstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rive Sarfstein Line = papers co-authored together Rive Sarfstein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20209
2 201948
3 201849
4 20184
5 201650
6 201631
7 201468
8 201448
9 20145
10 2013119
11 201132
12 201029
13 201030
14 201056
15 200651
16 2004114
17 200326
18 199014
19 199055
20 199011

About Rive Sarfstein

Rive Sarfstein is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Molecular Biology, having authored 51 papers that have together received 1.5k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (36 papers), Metabolism, Diabetes, and Cancer (26 papers), Cancer, Hypoxia, and Metabolism (15 papers), Research on Leishmaniasis Studies (4 papers), Cancer-related Molecular Pathways (4 papers), Pancreatic function and diabetes (4 papers), Genetic Syndromes and Imprinting (3 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (471 citations), Cancer Research (388 citations) and Molecular Biology (899 citations). Rive Sarfstein has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Haim Werner, Ilan Bruchim, Zvi Laron, Charles L. Jaffe, Ami Fishman, Sharon Maor, Karthik Nagaraj, Metsada Pasmanik‐Chor, Yara Gorzalczany and Edgar Pick. Their work appears in journals such as Cells, Frontiers in Endocrinology, European Journal of Cancer, Journal of Biological Chemistry and Growth Hormone & IGF Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026